4
Changes in Ownership
CRESCENT BIOPHARMA, INC. Filed Acc 0001628280-26-062706
Chief Medical Officer sold 623 shares at $17.90 ($11,152)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Im Ellie Eunkyung · Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-16 | Sale : show line 1 in the form 10b5-1 | −623 | $17.90 | $11,152 | 21,446 | D |
| Open-market sales · 623 sh · avg $17.90 · $11,152 | ||||||
Loading xslF345X06/wk-form4_1789761777.xml…